Smith Anglin Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $259K | Buy |
|
|||||
|
2024
Q4 | $207K | Sell |
|
|||||
|
2024
Q3 | $652K | Buy |
|
|||||
|
2024
Q2 | $616K | Buy |
|
|||||
|
2024
Q1 | $570K | Buy |
|
|||||
|
2023
Q4 | $283K | Sell |
|
|||||
|
2023
Q3 | $413K | Buy |
|
|||||
|
2023
Q2 | $451K | Buy |
|
|||||
|
2023
Q1 | $366K | Buy |
|
|||||
|
2022
Q4 | $458K | Sell |
|
|||||
|
2022
Q3 | $416K | Sell |
|
|||||
|
2022
Q2 | $500K | Buy |
|
|||||
|
2022
Q1 | $492K | Sell |
|
|||||
|
2021
Q4 | $595K | Buy |
|
|||||
|
2021
Q3 | $227K | Sell |
|
|||||
|
2021
Q2 | $221K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $228K | Buy |
|